Trial Profile
Sirolimus (Rapamune®) for Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD): a Randomized Controlled Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Mar 2014
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Autosomal dominant polycystic kidney disease
- Focus Therapeutic Use
- 19 Mar 2014 New trial record